Influence of XPD and APE1 DNA Repair Gene Polymorphism on Bladder Cancer Susceptibility in North India

Urology

Volumn 73, Issue 3, 2009, Pages 675-680

  Gangwar, Ruchika ^a   Ahirwar, Dinesh ^a   Mandhani, Anil ^a   Mittal, Rama Devi ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINE; ASPARTIC ACID; GLUTAMINE; LYSINE;

ADULT; AGED; APE1 GENE; ARTICLE; BLADDER CANCER; CANCER GRADING; CANCER RISK; CANCER STAGING; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DNA POLYMORPHISM; DNA REPAIR; FEMALE; GENE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TRANSITIONAL CELL CARCINOMA; XPD GENE;

CARCINOMA, TRANSITIONAL CELL; CASE-CONTROL STUDIES; DNA REPAIR; DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INDIA; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; URINARY BLADDER NEOPLASMS; XERODERMA PIGMENTOSUM GROUP D PROTEIN;

EID: 60549098237     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2008.09.043     Document Type: Article

References (28)

1. Sinha R., Anderson D.E., McDonald S.S., et al. Cancer risk and diet in India. J Postgrad Med 49 (2003) 222-228
2. Wu X., Zhao H., Suk R., et al. Genetic susceptibility to tobacco-related cancer. Oncogene 23 (2004) 6500-6523
3. Hoover R.N. Cancer-nature, nurture, or both. N Engl J Med 343 (2000) 135-136
4. Lichtenstein P., Holm N.V., Verkasalo P.K., et al. Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 343 (2000) 78-85
5. Bonassi S., Merlo F., Pearce N., et al. Bladder cancer and occupational exposure to polycyclic aromatic hydrocarbons. Int J Cancer 44 (1989) 648-651
6. Hu J.J., Mohrenweiser H.W., Bell D.A., et al. Symposium overview: genetic polymorphisms in DNA repair and cancer risk. Toxicol Appl Pharmacol 185 (2002) 64-73
7. Qiao Y., Spitz M.R., Shen H., et al. Modulation of repair of ultraviolet damage in the host-cell. Carcinogenesis 23 (2002) 295-299
8. Vogel U., Hedayati M., Dybdahl M., et al. Polymorphisms of the DNA repair gene XPD: correlations with risk of basal cell carcinoma revisited. Carcinogenesis 22 (2001) 899-904
9. Tomescu D., Kavanagh G., Ha T., et al. Nucleotide excision repair gene XPD polymorphisms and genetic predisposition to melanoma. Carcinogenesis 22 (2001) 403-408
10. Caggana M., Kilgallen J., Conroy J.M., et al. Associations between ERCC2 polymorphisms and gliomas. Cancer Epidemiol Biomarkers Prev 10 (2001) 355-360
11. Sturgis E.M., Zheng R., Li L., et al. XPD/ERCC2 polymorphisms and risk of head and neck cancer: a case-control analysis. Carcinogenesis 21 (2000) 2219-2223
12. Sreeja L., Syamala V.S., Syamala V., et al. Prognostic importance of DNA repair gene polymorphisms of XRCC1 Arg399Gln and XPD Lys751Gln in lung cancer patients from India. J Cancer Res Clin Oncol 134 (2008) 645-652
13. Terry P.D., Umbach D.M., and Taylor J.A. APE1 genotype and risk of bladder cancer: evidence for effect modification by smoking. Int J Cancer 118 (2006) 3170-3173
14. Popanda O., Schattenberg T., Phong C.T., et al. Specific combinations of DNA repair gene variants and increased risk for non-small cell lung cancer. Carcinogenesis 25 (2004) 2433-2441
15. Miller S.A., Dykes D.D., and Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16 (1988) 1215
16. Rybicki B.A., Conti D.V., Moreira A., et al. DNA repair gene XRCC1 and XPD polymorphisms and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 1 (2004) 23-29
17. Sanyal S., Festa F., Sakano S., et al. Polymorphisms in DNA repair and metabolic genes in bladder cancer. Carcinogenesis 25 (2004) 729-734
18. Ito H., Matsuo K., Hamajima N., et al. Gene-environment interactions between the smoking habit and polymorphisms in the DNA repair genes, APE1 Asp148Glu and XRCC1 Arg399Gln, in Japanese lung cancer risk. Carcinogenesis 25 (2004) 1395-1401
19. Excoffier L., and Slatkin M. Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol Biol Evol 12 (1995) 921-927
20. Larsson P., Wijkstrom H., Thorstenson A., et al. A population-based study of 538 patients with newly detected urinary bladder neoplasms followed during 5 years. Scand J Urol Nephrol 37 (2003) 195-201
21. Hoeijmakers J.H. Genome maintenance mechanisms for preventing cancer. Nature 411 (2001) 366-374
22. Ioannidis J.P., Ntzani E.E., Trikalinos T.A., et al. Replication validity of genetic association studies. Nat Genet 29 (2001) 306-309
23. Majumder M., Sikdar N., Ghosh S., et al. Polymorphisms at XPD and XRCC1 DNA repair loci and increased risk of oral leukoplakia and cancer among NAT2 slow acetylators. Int J Cancer 120 (2007) 2148-2156
24. Wu X., Gu J., Grossman H.B., et al. Bladder cancer predisposition: a multigenic approach to DNA-repair and cell-cycle-control genes. Am J Hum Genet 78 (2006) 464-479
25. Shen M., Hung R.J., Brennan P., et al. Polymorphisms of the DNA repair genes XRCC1, XRCC3, XPD, interaction with environmental exposures, and bladder cancer risk in a case-control study in northern Italy. Cancer Epidemiol Biomarkers Prev 12 (2003) 1234-1240
26. Benhamou S., and Sarasin A. ERCC2/XPD gene polymorphisms and lung cancer: A HuGE review. Am J Epidemiol 161 (2005) 1-14
27. Chang-Claude J., Popanda O., Tan X.L., et al. Association between polymorphisms in the DNA repair genes, XRCC1, APE1, and XPD and acute side effects of radiotherapy in breast cancer patients. Clin Cancer Res 11 (2005) 4802-4809
28. Khoury M.J., and Flanders W.D. Nontraditional epidemiologic approaches in the analysis of gene-environment interaction: case-control studies with no controls. Am J Epidemiol 144 (1996) 207-213